Evidence map›Paper›PMID 38871390›Full record

Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2024

Interreader and Intrareader Reproducibility of

Phillip H Kuo, Giuseppe Esposito, Gary A Ulaner, Don Yoo, Katherine Zukotynski, Gregory C Ravizzini, Ross Penny, Matthew P Miller, Albert Chau, Phillip Davis and 3 more

Abstract readMulticenter StudyClinical Trial, Phase III
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. An intra-patient contemporaneous comparison ofEuropean journal of nuclear medicine and molecular imaging · 2026
    Trial
  2. Review
  3. A Pilot Study ofThe Prostate · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Phillip H KuoDepartments of Medical Imaging, Medicine, and Biomedical Engineering, University of Arizona, Tucson, Arizona; kuoradiology@gmail.com.
Giuseppe EspositoDepartment of Nuclear Medicine, Medstar Georgetown University Hospital, Washington, District of Columbia.
Gary A UlanerDepartment of Molecular Imaging and Therapy, Hoag Family Cancer Institute, Irvine, California.
Don YooWarren Alpert Medical School of Brown University, Providence, Rhode Island.
Katherine ZukotynskiDepartment of Radiology, McMaster University, Hamilton, Ontario, Canada.
Gregory C RavizziniDivision of Diagnostic Imaging, Department of Nuclear Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
Ross PennyBlue Earth Diagnostics Ltd., Oxford, United Kingdom.
Matthew P MillerBlue Earth Diagnostics Ltd., Oxford, United Kingdom.
Albert ChauBlue Earth Diagnostics Ltd., Oxford, United Kingdom.
Phillip DavisBlue Earth Diagnostics Inc., Monroe Township, New Jersey.
Brian F ChapinDepartment of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas; and.
David M SchusterDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia.
SPOTLIGHT and LIGHTHOUSE study groups

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interreader and intrareader reproducibility of

Indexed as

Observer VariationPositron Emission Tomography Computed TomographyProstatic NeoplasmsAgedHumansImage Interpretation, Computer-AssistedMaleMiddle AgedNeoplasm Recurrence, LocalProspective StudiesRecurrenceReproducibility of Resultsinterreader variabilitymolecular imagingoncologyPET/CTPSMA

Identifiers

PMID38871390
PMCPMC11294070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.